DISCOUNT-OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 01:16:34 24/05/2024 am IST | ||
| 0.83 EUR | +7.79% |
|
| Current month | -30.63% | ||
| 1 month | -33.62% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 0.83 | +7.79% |
| 22/24/22 | 0.77 | +1.32% |
| 21/24/21 | 0.76 | -2.56% |
| 20/24/20 | 0.78 | -1.27% |
| 17/24/17 | 0.79 | +1.28% |
Real-time BOERSE MUENCHEN
Last update May 24, 2024 at 01:16 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD4KBP |
| ISIN | DE000HD4KBP4 |
| Date issued | 11/04/2024 |
| Strike | 285 $ |
| Maturity | 18/06/2025 (391 Days) |
| Parity | 10 : 1 |
| Emission price | 1.24 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.24 € |
|---|---|
| Lowest since issue | 0.75 € |
| Spread | 0.01 € |
| Spread % | 1.20% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
309.4
USD
Average target price
316.1
USD
Spread / Average Target
+2.15%
- Stock Market
- Certificates
- Certificat
